Some 60 years ago an oxidation product of adrenaline, adrenochrome, was discovered (Fig. l) , which is responsible for the pink coloration that occurs when concentrated solutions of adrenaline are exposed to the air. Although no physiological role for this metabolite has been established, it has been reported that adrenochrome produces myocardial necrosis, cardiomyopathy, coronary artery constriction and arrhythmias in uitro (Beamish etal., 1981; Yates et al., 1981; Karmazyn ef al., 1981) .
We now report the oxidation of adrenaline to adrenochrome by polymorphonuclear leucocytes and propose that this could provide a mechanism for producing adrenochrome in cardiac diseases in which infiltration by these leucocytes occurs. These include myocardial infarction, where there is massive infiltration around the infarct, and some cardiomyopathies, infections and rheumatic heart disease, where the infiltration by polymorphonuclear leucocytes is more diffuse.
Rat polymorphonuclear leucocytes were prepared as described by Hallett et al. (198 1) . Adrenochrome was measured spectrophotometrically at the peak absorbance at 480nm ( E~~~ = 2650h1-'. cm-l), where adrenaline absorbance was undetectable.
Polymorphonuclear leucocytes alone oxidized adrenaline (0.01-1.0m~) to adrenochrome, which was detectable within 30-60min. Addition of latex beads (4 x lo9 beads/ml) as a phagocytic stimulus enhanced this oxidation 7-10-fold. Under these conditions adrenochrome was detectable within 5 min, and its production continued for at least 6 h, when the percentage conversion was 50%. This conversion into adrenochrome was dependent on cell and bead concentration, but was apparently independent of adrenaline concentration. When adrenaline was added to the extracellular fluid from cells previously incubated with a phagocytic stimulus, adrenochrome was also detectable. This oxidation was inhibited by azide, superoxide dismutase and catalase. The synthetic peptide N-formylmethionyl-leucylphenylalanine, an analogue of the active part of complement component C3a, also stimulated the release of a factor(s) that oxidized adrenaline to adrenochrome. The percentage conversion was of a similar magnitude to that caused by the phagocytic stimulus. This could be pathologically significant, since it has been reported that the chemotactic peptide C3a is responsible for attracting polymorphonuclear leucocytes to the site of tissue injury after myocardial infarction (Hill & Ward, 1971) .
Infiltration of polymorphonuclear leucocytes, at concentrations similar to those used in the experiments conducted in uitro, occurs in several myocardial diseases, including infarction. The question therefore arose: was the factor(s) that oxidized adrenaline in uitro also released by polymorphonuclear leucocytes in uioo? In order to investigate this, adrenaline ( 5 0 0~~) was added to fresh serum and the mixture incubated at 37OC for 2h. Serum from six patients 2-14 days after myocardial infarction oxidized adrenaline to adrenochrome. The percentage conversion in 2 h varied from 8% to 44%. In contrast, the conversion of adrenaline to adrenochrome in the serum for six control subjects was less than 7% in all cases.
It was concluded that polymorphonuclear leucocytes secrete a substance that can oxidize adrenaline to adrenochrome. A similar substance was found in serum from patients after myocardial infarction. Polymorphonuclear leucocytes when stimulated produce oxygen radicals (e.g. O;, OH', 'OJ. These short-lived reactive species are unlikely to account for the oxidation of adrenaline to adrenochrome observed in the extracellular fluid. However, a role for OC1-and H,O,, also known to be produced by polymorphonuclear leucocytes, cannot be ruled out. The anion OC1-is produced by reaction of H,O, with C1-and is catalysed by myeloperoxidase. This enzyme is also known to have oxidase activity. It remains to be established whether myeloperoxidase is the cause of adrenaline oxidation, and whether adrenochrome occurs in uivo.
